Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive Bladder Cancer

The Journal of Urology
Carmen V LeitnerTobias Klatte

Abstract

Conditional estimates provide a dynamic prediction of outcomes but to our knowledge there are no data on nonmuscle invasive bladder cancer. We assessed changes in conditional recurrence and progression rates after transurethral resection of the bladder and explored the prognostic impact of established factors and risk groups with time. We retrospectively analyzed data on 1,292 consecutive patients with newly diagnosed Ta/T1 bladder cancer who underwent transurethral resection of the bladder. Study end points were time to first recurrence and time to progression. The 2-year recurrence rate at baseline was 36%, which improved as a function of the time that patients were free of disease recurrence. After 6, 12, 24, 36 and 48 months the 2-year conditional recurrence rate improved to 31% (14% improvement vs baseline), 22% (39% improvement), 16% (56% improvement), 13% (64% improvement) and 11% (69% improvement), respectively. Comparably, conditional progression rates improved with increasing followup, although relative differences were less distinct. The prognostic impact of established factors and nonmuscle invasive bladder cancer risk groups progressively decreased with time and finally disappeared. However, bacillus Calmette-Guéri...Continue Reading

References

Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maryska L G Janssen-HeijnenJan-Willem W Coebergh
Jul 31, 2010·Advances in Urology·Ali A Al-Zahrani
Mar 2, 2011·Cancer·Rodolphe ThuretPierre I Karakiewicz
Dec 27, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maxine SunPierre I Karakiewicz
Jul 4, 2012·International Journal of Cancer. Journal International Du Cancer·Freddie BrayJacques Ferlay
Oct 10, 2012·BMC Cancer·Xue Qin YuDianne L O'Connell
Jul 6, 2013·European Urology·Marko BabjukUNKNOWN European Association of Urology
Aug 6, 2013·Cancer·Emily C ZaborKatherine S Panageas
Jul 25, 2014·PharmacoEconomics·Christina YeungJoseph Lee
Aug 26, 2014·European Urology·Guillaume PloussardWassim Kassouf
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Apr 11, 2015·World Journal of Urology·Ines A EdererTobias Klatte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.